Skip to main content
Clinical Trials/DRKS00026622
DRKS00026622Not yet recruitingNot Applicable

Respiratory microbiome and clinical data analysis for the prediction of acute exacerbations in COPD - Longitudinal study - REDALERT C

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main0 sites300 target enrollmentStarted: October 8, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • 1. Written informed consent
  • 2. Physician-confirmed diagnosis of COPD (spirometry) (FEV1 = 80% predicted)
  • 3. Smoking history: Min. 10 packyears

Exclusion Criteria

  • 1.Inability to understand the nature, scope, and possible consequences of the study
  • 2. Life expectancy of less than 12 months
  • 3. Newly diagnosed active pulmonary tuberculosis within the last 12 months
  • 4. Unstable cardiopulmonary or metabolic co-morbidities
  • 5. Macrolide maintenance treatment

Investigators

Sponsor
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main

Similar Trials

Respiratory microbiome and clinical data... | Clinical Trial